Publication of Pricing Supplement

Summary by AI BETAClose X

Standard Life plc has published a Pricing Supplement dated 15 October 2026 detailing the issue of £300,000,000 Fixed Rate Reset Tier 2 Notes due 2056 under its £5,000,000,000 Euro Medium Term Note Programme. These Notes are intended for admission to trading on the London Stock Exchange's International Securities Market and their final terms are outlined in the supplement, which should be read alongside the offering circulars dated 17 July 2026 and 10 September 2026.

Disclaimer*

Standard Life plc
15 October 2026
 

Standard Life plc (LEI: 2138001P49OLAEU33T68)

 

15 October 2026

 

Publication of Pricing Supplement

 

The Pricing Supplement dated 15 October 2026 in relation to the issue of £300,000,000 Fixed Rate Reset Tier 2 Notes due 2056 (the "Notes") under the Standard Life plc £5,000,000,000 Euro Medium Term Note Programme (the "Programme") is available for viewing.

 

The Pricing Supplement contains the final terms of the Notes and must be read in conjunction with the offering circular dated 17 July 2026 relating to the Programme, as supplemented by
the supplementary offering circular dated 10 September 2026 (the "Offering Circular").
Application has been made to the London Stock Exchange plc for the Notes to be admitted to trading on the London Stock Exchange's International Securities Market.

 

To view the full document, please paste the following URL into the address bar of your browser.

 

http://www.rns-pdf.londonstockexchange.com/rns/1897Z_1-2026-10-15.pdf

 

A copy of the Pricing Supplement has also been uploaded to the website of Standard Life plc and will shortly be available at https://www.standardlifeplc.com.

 

For further information, please contact:

 

Standard Life plc

Office: 20 Old Bailey, London, EC4M 7AN

Website: https://www.standardlifeplc.com

 

Media
Shellie Wells, Corporate Communications Director, Standard Life plc

+44 (0) 204 559 3031

Investors
Joanne Roberts, Group Strategy and Investor Relations Director, Standard Life plc

+44 (0) 204 559 4673

 

Tom Blackwell

Managing Director, FTI

+44 (0) 7747 113 919

 

 

DISCLAIMER - INTENDED ADDRESSEES

EU MiFID II professionals/ECPs only/No EEA PRIIPs KID

UK MiFIR professionals/ECPs only/No DISC disclosure document

Please note that the information contained in the Pricing Supplement and the Offering Circular may be addressed to and/or targeted at persons who are residents of particular countries only and is not intended for use and should not be relied upon by any person outside these countries. Prior to relying on the information contained in the Pricing Supplement and the Offering Circular, you must ascertain from the Pricing Supplement and the Offering Circular whether or not you are part of the intended addressees of the information contained therein.

In particular, none of this announcement, the Pricing Supplement or the Offering Circular shall constitute an offer to sell or the solicitation of an offer to buy securities in the United States or in any other jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration, exemption from registration or qualification under the securities laws of any such jurisdiction.

The Pricing Supplement and the Offering Circular do not constitute an offer of securities for sale in the United States or to U.S. persons. The Notes described therein have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act") or under any relevant securities laws of any state of the United States and may not be offered or sold to U.S. persons (as defined in Regulation S under the Securities Act) or to persons within the United States, except pursuant to an exemption from the Securities Act.

Your right to access this service is conditional upon complying with the above requirement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings